---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298647011.md"
description: "During Thursday's after-market session, several healthcare stocks experienced significant price movements. Gainers included AEON Biopharma (+8.9%), Picard Medical (+7.97%), and Apimeds Pharmaceuticals (+7.83%). Conversely, losers featured PDS Biotechnology (-8.9%), Myriad Genetics (-7.8%), and CollPlant Biotechnologies (-5.37%). These fluctuations reflect trading activity in the small-cap healthcare sector following the regular market close."
datetime: "2026-09-10T21:06:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298647011.md)
  - [en](https://longbridge.com/en/news/298647011.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298647011.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **AEON Biopharma** (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million.
-   **Picard Medical** (AMEX:PMI) stock moved upwards by 7.97% to $4.76. The market value of their outstanding shares is at $9.0 million.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) stock increased by 7.83% to $2.34. The market value of their outstanding shares is at $3.4 million.
-   **XORTX Therapeutics** (NASDAQ:XRTX) shares moved upwards by 7.79% to $2.35. The market value of their outstanding shares is at $3.9 million.
-   **NeuroOne Medical Tech** (NASDAQ:NMTC) shares rose 7.59% to $1.7. The market value of their outstanding shares is at $15.1 million.
-   **Tenon Medical** (NASDAQ:TNON) shares moved upwards by 6.77% to $5.66. The market value of their outstanding shares is at $1.6 million.

### Losers

-   **PDS Biotechnology** (NASDAQ:PDSB) shares decreased by 8.9% to $0.29 during Thursday's after-market session. The market value of their outstanding shares is at $16.3 million.
-   **Myriad Genetics** (NASDAQ:MYGN) shares decreased by 7.8% to $3.1. The company's market cap stands at $301.2 million.
-   **CollPlant Biotechnologies** (NASDAQ:CLGN) shares fell 5.37% to $3.35. The market value of their outstanding shares is at $6.4 million.
-   **Gelteq** (NASDAQ:GELS) stock decreased by 5.2% to $0.75. The company's market cap stands at $9.1 million.
-   **SenesTech** (NASDAQ:SNES) shares fell 4.93% to $0.85. The company's market cap stands at $4.6 million.
-   **Quoin Pharmaceuticals** (NASDAQ:QNRX) shares fell 4.79% to $6.57. The market value of their outstanding shares is at $13.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)
- [AEON.US](https://longbridge.com/en/quote/AEON.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md)
- [PDSB.US](https://longbridge.com/en/quote/PDSB.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [XRTX.US](https://longbridge.com/en/quote/XRTX.US.md)
- [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md)
- [TNON.US](https://longbridge.com/en/quote/TNON.US.md)
- [GELS.US](https://longbridge.com/en/quote/GELS.US.md)
- [SNES.US](https://longbridge.com/en/quote/SNES.US.md)
- [QNRX.US](https://longbridge.com/en/quote/QNRX.US.md)
- [TNONW.US](https://longbridge.com/en/quote/TNONW.US.md)
- [74907L409.US](https://longbridge.com/en/quote/74907L409.US.md)

## Related News & Research

- [CollPlant unit LightSolver files U.S. provisional patent expanding photonic computing to PDE simulations](https://longbridge.com/en/news/301025540.md)
- [PDS Biotech hosts virtual KOL event on PDS0301 in advanced colorectal cancer with liver metastases](https://longbridge.com/en/news/301032572.md)
- [Picard Medical Issues Convertible Notes and Equity Warrants](https://longbridge.com/en/news/301061566.md)
- [Picard Medical issues $1 million of 3% unsecured convertible notes to accredited investors](https://longbridge.com/en/news/301059666.md)
- [CollPlant Biotechnologies GAAP EPS of -$0.87, revenue of $11.43M; reaffirms FY 2026 outlook](https://longbridge.com/en/news/300648837.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**